Meyka AI API is live for developers.Start building.
Advertisement
Becton, Dickinson and Company

Becton, Dickinson and Company (BDXA) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

BDXA●NYSE
HealthcareMedical - Instruments & Supplies
$59.24
$1.36(2.24%)
U.S. Market opens in NaNh NaNm
Advertisement

Becton, Dickinson and Company (BDXA)

Meyka AI Score

Z

Key Financials

Market Cap55.9B
P/E Ratio37.42
EPS (TTM)$2.76
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

BDXA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Becton, Dickinson and Company (BDXA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 37.42 and a market capitalization of 55.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-1.58%
5-Year Change
2.14%
All-Time (Max) Change
13.49%

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

IPO DateMay 11, 2017
CountryNaN

Frequently Asked Questions